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In a previous paper (3), it was reported that the primary atypical pneumonia 
(PAP) virus can be detected by fluorescent antibody staining of the bronchial 
epithelium in infected chick embryos. It has also been found that a  component 
in fresh normal human or guinea pig serum enhances the reaction between the 
PAP virus and the specific antibody in human convalescent sera (2). This serum 
component has many of the properties of complement. It is heat-labile, is re- 
movable by specific immune precipitates, and its activity requires the presence 
of calcium and magnesium ions. Detailed studies of the enhancing action of this 
serum factor will be presented in a separate communication (4). 
The present paper is concerned with the development and the persistence of 
antibody in human patients with PAP infection,  the relationship of the PAP 
antibody to the "cold" and streptococcus MG agglutinins, and the use of the 
fluorescent-staining  reaction as a  specific serological diagnostic  test for PAP. 
In 1943, two independent groups, Turner (5) and Peterson et al. (6) reported that 
the sera of patients convalescent from PAP agglutinated human type O cells in the 
cold and subsequently this was named "cold agglutinin." The cold agglutinin is not 
always present in patients' sera. Where it occurs, the range reported varies from 20 to 
90 per cent (7) and is apparently related to the severity of the illness. In 1945, Thomas 
et al. (8) reported the isolation of a non-hemolytic streptococcus (MG) from the spu- 
tum and lungs of patients with primary atypical pneumonia, and found that between 
20 and 75 per cent of the patients develop MG agglutinins depending on the severity 
of the illness. Immunological studies have shown that the streptococcus MG and the 
* A portion of this work has been reported to the New York Academy of Medicine, Novem- 
ber 16, 1955 (1) and to the Association of American Immunologists, April 18, 1957 (2). 
:~ This work was done under the sponsorship of the Commission  of Immunization, Armed 
Forces Epidemiological  Board, and was supported by the Office  of the Surgeon General, De- 
partment of the United States Army. 
§ Present address: Department  of Pediatrics, University of Kansas School of Medicine, 
Kansas City, Kansas. 
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cold agglutinins are not related (8). Although these two reactions are not specific for 
PAP infection, they have commonly been used in the laboratory as adjuncts to diagno- 
sis of primary atypical pneumonia for which no specific test was available. The cotton 
rat neutralization test for PAP virus developed by Eaton and van Herick (9) has not 
been generally  applied  owing  to  the  difficulty  of  finding  uniformly  susceptible 
animals,  as different breeds of cotton rats may show varying degrees of susceptibility 
to the PAP virus infection (10). 
Materials and Methods 
Viruses.--Antibody  titrations were usually done on either the Mac or the F.H. strain of 
PAP virus (3), although any of the 8 strains of PAP virus in our possession  may be used for 
serological diagnosis,  for they are all closely related antigenically. 
Screening and Titration of PAP Antibody.--Infeeted  chick embryo lungs were screened with 
a human convalescent serum known to contain PAP antibody. Only those lungs which showed 
good intensive fluorescent staining for PAP viral antigen in several bronchioles or air sacs 
were selected for antibody titration. A series of sections from these infected embryos was cut 
and stored at 4°C. These sections were usually used within a week, although it was found that 
they could be used after being stored at refrigerator temperature for about 2 weeks. All human 
sera were inactivated at 56°C. for 30 minutes. Serial 2-fold dilutions starting at ~o were made 
in 0.85 per cent NaC1 solution. To each 0.2 ml. of serum dilution, one drop (about 0.02 mi.) of 
fresh normal human serum was added from a  capillary pipette. The normal serum had been 
previously tested and shown to be non-reactive for PAP antibody at a dilution of ~. In more 
recent experiments, serial 2-fold diintinos of antiserum starting at ~0 were made directly in a 
0 dilution of freshnormal human serum in veronal buffer saline. This procedure was found to 
be not only more convenient, but also more precise. The method for staining the sections with 
fluorescein-labelled antibody has been described (3). In reading the results, slides stained with 
various serum dilutions were arranged in random order and the examiner graded the intensity 
of the specific fluorescence present as -t- to ++++.  The highest serum dilution giving a  + 
staining reaction was taken as the endpoint of antibody titration. Screening of sera was done on 
~{o dilutions, and if no staining was seen,  the serum was considered to be negative. One in- 
fected embryo lung usually provided 200 to 300 sections (4 to 6 microns thick), enough for 
many antibody titrations.  To give comparable results, acute and covalescent sera from the 
same patient were always titrated on sections from the same embryo. 
Titration of Streptococcus MG and Cold A gglutinins.--The  methods used for these titrations 
have been described by Smadel (11). A culture of streptococcus MG organisms was obtained 
through the courtesy of Lieutenant Colonel Robert B. Lindberg of the Waiter Reed Army 
Medical Center, Washington, D.C. The MG antigen was prepared in our laboratory according 
to his instructions. For cold agglutinin titrations, human type 0  cells were used. 
Absorption of Sera.--The methods for the absorption of cold and MG agglutinins are de- 
scribed in the text. For absorption  of the sera with animal  tissue powder, the method  as 
described for absorption of fluorescent antibody solutions was used (12). 
EXPERIMENTAL RESULTS 
Choice of Pationts.--A  group of patients in a  boys' private school provided the essential 
materials for the serological  studies. An epidemic of respiratory illness involving 20 patients 
with clinical and roentgenological findings consistent with primary atypical pneumonia oc- 
curred between the end of September, 1952, and January,  1953. Most of these patients also 
developed cold agglutinln (Table I). From these 20 patients, sera were collected on admission 
to the infirmary and again 2 and 4 weeks later during convalescence. From three patients, C.  LIU~  M.  D.  EATON~  J.  T.  HEYL  547 
sputum and throat washings were also collected. The inoculation of these specimens into cotton 
rats intranasal]y  was followed by the development of pneumonia. However, attempts at that 
time to isolate a virus by inoculating the sputum into chick embryos failed. Nine pairs d  sera 
were tested  against  the Mac strain of PAP virus by neutralization  tests in cotton rats. They 
showed a rise of antibody  during convalescence. The majority of the sera remained frozen at 
--20°C. until  1954. 
In September, 1954, when it was found that the PAP virus could be detected in the infected 
chick embryo lungs by means of fluorescent staining, a serological test for PAP infections be- 
came available. Therefore all 20 pairs of sera previously collected during the 1952-53 epidemic 
were tested for the PAP antibody.  Subsequently, additional  sera were collected from sporadic 
TABLE I 
Correlation of Positive PAP Fluorescent-Staining Antibody  to Positive Cold Agglutinins 
No.  with  positive  Year  Location  No. patients  cold  agglutinins  Per  cent 
1952  Exeter,  N.H.  20  19/20  95 
1953  Cambridge  5  4/5  80 
1954-5  Exeter, N.H.  6  5/6  83 
TABLE II 
Time of Appearance and Titers of Antibody in Sera of Human Patients Convalescent "tom  PAP 
Fluorescent-stalnlng titer* 
No. 
sera 
Serkl/n 
collected 
o~ days 
1-7 
8-14 
15-20 
21-30 
31-40 
>40 
23 
18 
17 
15 
16 
16 
105 
19 
5 
1 
0 
0 
0 
10  20  40 
0  1 
0  2 
0  1 
0  0 
0  0 
0  1 
8O  160 
1 
5 
5 
8 
5 
5 
320  640  1280 
0  0  0 
2  2  0 
2  4  0 
2  3  2 
3  4  0 
3  1  0 
Positive  Neg-  Percentage 
I0 or >  ative  offl~ositive  <1o 
4  19  17 
13  5  72 
16  1  94 
15  0  100 
16  0  100 
16  0  100 
* Antibody titrations were carried out with the addition  of fresh normal human  serum. 
~: Reciprocal  of  serum  dilution. 
cases of clinical PAP occurring in the same school during  1955 and 1956. At the same time, 
sputum  and sera were obtained from patients in the Boston-Cambridge area. Virus isolations 
and serological tests were performed with these specimens (3). 
Development  of Antibody.--The  development of  PAP  antibody  was  deter- 
mined by the fluorescent staining  technic on a  group of 43 patients  who had 
PAP antibody in their convalescent sera and for whom the time of onset of dis- 
ease was known (Table II and Fig. 1).  It can be seen that only 17 per cent of 
the sera collected during the 1st week of illness had an antibody titer of 1/10 
or higher. The percentage of positive sera increased in the 2nd and the 3rd week 
and all of the sera collected after the 3rd week were positive. It should be noted 548  PRIMARY ATYPICAL PNEUMONIA.  II 
that the four positive sera with a  fiter over 1/10 during the 1st week of illness 
were collected on the 5th and the 6th day of illness. 
Persistence of PAP Antibody.--Sera  from six patients  were followed peri- 
odically for a year or longer (Table III). In two of these patients (W. E. and 
H. R.), antibody titers started to decline within 4 to 6 months after the illness. 
By 12 to 18 months after the infection, the drop of antibody in all sera was 4- 
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FIG. 1. Development  of PAP fluorescent-staining  antibody in sera of 43 patients 
fold or greater, but still persisted at detectable levels. In four of these patients 
(A. S., C. P., W. E., and H. R.), both the cold and streptococcus MG agglutinins 
were also followed. The first two patients had no cold or streptococcus MG 
agglutinins to start with. In the last two patients, both the cold and streptococ- 
cus MG agglutinins had returned to normal levels in the specimens collected 
4 to 6 months after the illness. 
Comparison of Antibody Response by Neutralization in Cotton rats and Flu- 
orescent Staining.--The sera from nine patients were titrated both by neutrali- 
zation tests in cotton rats and by fluorescent staining. The neutralization tests 
were performed in the Spring of 1953 using the Mac strain of virus isolated in C.  LIU,  M.  D.  EATON,  J.  T.  HEYL  549 
California in 1944 (13). The fluorescent staining was done in 1955 and 1956 on 
the same sera using both the recently isolated strains and the Mac strain of 
virus as antigens,  since it has been shown  that  all available strains of PAP 
virus in our laboratory are antigenically closely related if not identical (3). 
As shown in Table IV, the rise of antibody tested both by neutralization and 
fluorescent staining  paralleled each other except in one case (P. H. R.)  whose 
sera did not show a rise of antibody by neutralization test and had only a 2-fold 
rise of antibody when tested by fluorescent staining. Owing to the small number 
of cotton rats available, many neutralization  titrations  could not be carried 
out to the endpoints. 
Serological  Diagnosis  of PAP Infection.--Sera  from 89 patients  have been 
titrated  for PAP  antibody by the  indirect  fluorescent-staining  method.  The 
results are tabulated in Table V. 
TABLE III 
Persistence of PAP Antibody in Human Convalescent Sera 
Sera collected at 
1st wk  ..................... 
2nd to 3rd wk  .............. 
1 to 3  mos  ................. 
4  to 6  mos  ................. 
9 to 12 mos  ................ 
12 to 18 mos  ............... 
A.S. 
< 10" 
320 
>160 
320 
160 
80 
Patients 
C.P. 
nd~ 
160 
160 
8O 
4O 
4O 
W.]~. 
m 
nd 
8O 
40 
nd 
H.R. 
nd 
640 
nd 
8O 
4O 
20 
M.B. 
<10 
nd 
160 
320 
nd 
4O 
T.G. 
nd 
nd 
80 
80 
40 
10 
* Reciprocal  of  serum  dilution. 
:~ nd,  no data. 
The first group of 38 patients  was from a  boys' private school at Exeter, 
New Hampshire. In 34 of them, there was a  definite rise of antibody titer be- 
tween 8- and 128-fold in the convalescent sera, which made the diagnosis un- 
equivocal.  In one patient,  the first serum,  collected during  the  2nd  week of 
illness, had a  titer of 1/160 and a second serum collected from him in the 4th 
week did not show a  further rise.  However, such a  high titer was consistent 
with a recent PAP infection. The remaining three patients had a titer of 1/20 
and 1/40 in their sera collected during the 1st week of illness and subsequent 
sera did not show more than a  2-fold rise. 
In the  second  group,  30 pairs  of sera from patients  in  Boston and  Cam- 
bridge,  were collected.  Some of these sera were from hospital patients while 
other sera were sent in by local physicians to the Massachusetts State Public 
Health Diagnostic Laboratory) Most  of these patients had pneumonia pre- 
1 We are grateful to Mrs. Joan B, Daniels for making these specimens available. 550  PRIMARY  ATYPICAL  PNEUMONIA.  II 
sumably not of bacterial origin. Of  these sera,  20  (67  per cent)  had a  4-fold 
or greater rise of antibody during convalescence when tested by PAP fluores- 
cent staining. 
TABLE IV 
Comparison of PAP Antibody  Titration by Neutralization in Cotton Rats and 
Fluorescent-Staining Reactions 
Fluorescent  Patient  Date of ~ra  Cold agglutiuin  Neutralization  staining 
F.H. 
A. S. 
J. R. 
P° G. 
R. W. B. 
A. E. 
P. H. R. 
P.  S. 
T. C. 
Dec. 10, 1954 
Dee. 22, 1954 
Mar. 16, 1955 
Dec. 8, 1954 
Dec. 16, 1954 
Feb. 3, 1955 
Nov. 6, 1952 
Dec. 4, 1952 
Oct. 28, 1952 
Nov. 24, 1952 
Oct. 30, 1952 
Dec. 4, 1952 
Oct. 30, 1952 
Nov. 20, 1952 
Oct. 30, 1952 
Nov. 28, 1952 
Oct. 30, 1952 
Nov. 13, 1952 
Nov. 28, 1952 
Oct. 30, 1952 
Nov. 13, 1952 
Dec. 1, 1952 
<4 
<4 
<4 
<4 
<4 
<4 
4 
<4 
<4 
16 
8 
64 
<4 
32 
<4 
4 
<4 
32 
8 
<4 
32 
4 
<4 
8* 
8 
<4 
>32t 
16 
<4 
>16 
<4 
>16 
<4 
>16 
<4 
>16 
4 
<8 
<4 
nd§ 
8 
<4 
nd 
16 
<10 
160 
160 
<10 
320 
320 
20 
640 
<10 
160 
<10 
80 
<10 
160 
20 
40 
<10 
nd 
640 
<10 
nd 
320 
* Reciprocal  of serum  dilution. 
:~ Complete neutralization at this dilution; higher dilution not tested. 
§nd,  no  data. 
In the third group, only one serum specimen was collected from each of 21 
patients  3  weeks  or  longer after  an  illness diagnosed as  non-bacterial pneu- 
monia.  Two  of  these  patients  died.  In  this  group,  14  sera  (67  per  cent), 
including the two fatal cases, had PAP antibody at a  level of 1/~o dilution or 
higher. C.  LIU,  M'.  D.  EATON,  J.  T.  HEYL  551 
As to the specificity of the test, it has been reported (3) from this laboratory 
that PAP virus does not cross-react with human or rabbit sera known to con- 
tain antibody against psittacosis, Q fever, influenza A, influenza B, adenovims 
(types 1 to 6), or pneumonia virus or mice. 
Relation  of PAP Fluorescent-Staining  Antibody  to  the Cold Aggtutinin  and 
Streptococcus MG Agglutinin.--Although  positive reactions of cold agglutina- 
tion  on  streptococcus  MG  agglutination in  human  convalescent  sera  may 
help to substantiate the diagnosis of primary atypical pneumonia, no experi- 
mental data have become available to explain the relation of these antibodies 
to the disease (5, 6, 8). In one group of 17 patients studied in our laboratory 
in whom the PAP infection was established by antibody rise and/or positive 
isolation of virus,  7 did not develop any detectable cold agglutinin. Only 30 
per  cent  of  our patients  with fluorescent-staining PAP  antibody developed 
TABLE  V 
Results of Serological Diagnosis of Human PAP Infections 
Sera from 
Exeter, N.  H ..................... 
Boston-Cambridge ................ 
Boston-Cambridge ................ 
No. of sers per patient 
2 or more 
2 
1 
Result 
Positive*  Negative~; 
35  ]  3 
20  10 
14§  7 
Per cent 
positive 
92 
67 
67 
* Positive, a  4-fold or greater rise of antibody titer during convalescence. 
:~ Negative, less than a  4-fold rise of antibody titer during convalescence or the antibody 
titer  was  less  than  1/I0  dilution. 
§ Antibody titer of the single serum specimen greater than  1/10. 
the MG agglutinin. The titers of cold agglutinin usually decline to non-signifi- 
cant levels 4 to 6 weeks after infection (14)  and the titers of MG agglutinin 
may decline during the 7th and the 8th week after infection (8).  However, 
the PAP fluorescent-staining antibody is detectable for a year or longer after 
the illness (Table III). 
To collect additional evidence that cold and MG agglutinins are not related 
to  the  PAP  antibody,  cross-absorption  experiments  were  performed.  Con- 
valescent sera from patients who showed high PAP antibody titers and cold 
or MG agglutinins were diluted to ~  with 0.85  per cent saline. Each serum 
was divided into two portions. One portion was stored at 4°C. as control, the 
other portion was absorbed either with washed human type O erythrocytes or 
with  washed heat-killed MG organisms.  The  absorption  was  performed by 
mixing 0.3 ml. packed washed human O cells or MG organisms with 1 ml. of 
the diluted serum and allowing the tubes to stand at 4°C. for 6  hours with 
occasional agitation. At the end of 6 hours, the serum was separated by cen- 
trifugation and  the  supernatant  was  reabsorbed  again with 0.3  ml.  packed 552  PRIMARY ATYPICAL PNEUMONIA. II 
erythrocytes or bacteria at 4°C.  overnight.  Finally,  the absorbed serum was 
recovered by centrifugation and  tested  for cold  or MG agglutinins  and  for 
fluorescent-staining  reaction  of  the  PAP virus.  The  results  are  summarized 
in the Tables VI and VII. 
As shown in Table VI, absorption of serum with human O  cells at 4°C. re- 
moved practically all the cold agglutAnin, yet there was no effect on the fluores- 
cent staining of the PAP virus. After the patient's serum was absorbed with 
TABLE VI 
Rdationskip  of Cold Agglutinln  to PAP Antibody 
Patient  Absorption  Cold aggluthain  PAP staining 
H.R. 
T. V. 
None 
Human "0" cells 
None 
Human "O" cells 
80* 
<5 
80 
<5 
40 
40 
160 
160 
* Reciprocal of serum dilution. 
TABLE VII 
Relationship of Streptococcus MG Agglutlnln  to PAP Antibody as Tested by Absorption 
with MG Organisms 
Treatment of aliquots  of serum W.E. 
A. Unheated, no absorption  ......................... 
B.  "A" +  fresh normal human serum (A. L.) ......... 
C.  Unheated absorbed 2 X MG ..................... 
D. "C" +  fresh normal human serum (A. L.) ......... 
E.  Fresh normal serum (A. L.) only  .................. 
MG 
agglutination 
32* 
32 
<4 
<4 
<4 
Fluorescent  staining  on: 
~.--M?ears  PAP160virus 
nd~  [  320 
10  /  40 
nd  160 
nd  <5 
*Reciprocal  of  serum dilution. 
nd, no data. 
MG organisms  (Table VII),  the  MG agglutinin and  the  antibody responsi- 
ble for the fluorescent staining reaction of MG organisms were reduced.  The 
absorption  of  unheated  serum,  W.  E.,  with  streptococcus MG  apparently 
removed  some  of  the  heat-labile  factor  which  intensifies  the  staining  with 
PAP virus,  thus  dropping  the  observed  tAter 4-fold in  the  absence  of fresh 
normal human serum. However, when fresh normal human serum was added 
to the serum dilutions, the tater was restored to its former level. 
To elucidate the relationship between MG agglutinin and the PAP antibody 
further, two groups of rabbits were immunized to determine if cross-reactions C.  LIU, M.  D.  EATON~ J.  T.  HEYL  553 
could be found in  the serum  (Table VIII). One  group was immuniT~l with 
MG  organisms and  the  other  group  with  PAP-infected  chick  embryo lung 
suspensions.  It can be seen that rabbits immunized with MG had developed 
a  high  agglutinin  titer for the  organisms but no antibody reactive with  the 
PAP virus. Conversely, rabbits immunized with PAP virus failed to develop 
TABLE  VIII 
Relationship  of MG Agglutlnin  to PAP Antibody  as Tested by Immunization of Rabbits 
Rabbit sera 
Pre-immunization.. 
Immunized with MG ..... 
Pre-immunization... 
Immunized with PAP virus... 
MG agglutinln 
<2* 
2O48 
<2 
<2 
PAP staining 
<10 
<10 
<10 
>160 
PAP neutralization 
nO~ 
nd 
<8 
>256 
* Reciprocal of serum dilution. 
nd, no data. 
TABLE  IX 
Effect of Absorption of Human Serum with Tissue Powder on the Fluorescent Staining 
of PAP Virus 
Absorption 
None ........................... 
1 X chick embryo powder ........ 
2 X chick lung powder .......... 
2 X mouse liver powder ......... 
1/20" 
++++~ 
++++ 
++++ 
++++ 
Degree of fluorescent  staining at: 
1/~  11~  1/i~  1[3~ ]  1[~  i 
.......  I 
++++  +++  ++  ~  0 
++++  +++  ~+ 
++++  ~+  +  + 
++++  +  ±  0 
* Serum  dilution  with  fresh  normal  human  serum  added. 
S Degree of  specific fluorescent  staining:-- 
+ + + +  maximum intensity 
+  definite but weak 
:i= doubtful 
0 no staining 
MG  agglutinin  but  developed  fluorescent-staining  antibody  as  well  as  neu- 
tralizing  antibody against the homologous virus. The data here  clearly  indi- 
cate that the MG agglutinin and the PAP antibody are not related. 
Effect of Absorption  of Convalescent Serum with Tissue Powder.--It  has been 
reported that some convalescent sera from PAP patients contain non-specific 
complement-fixing  antibody  against  dissimilar  tissue  antigens  (15).  How- 
ever,  absorption  of  the  convalescent  serum  (Table  IX)  with  chick  embryo 
powder,  chick lung powder, or mouse liver powder did not affect the specific 
fluorescent-staining antibody of the PAP virus. 554  PRIMARY  ATYPICAL  PNEUMONIA.  II 
DISCUSSION" 
From the evidence presented, it is concluded that among patients clinically 
designated as having primary atypical pneumonia, there is a  distinct entity, 
associated with the development of cold agglutinin, which is caused by a spe- 
cific virus.  In these patients,  the specific  antibody against the PAP  virus as 
measured by the  fluorescent staining technic appeared  during  the  2nd and 
the 3rd week of the illness and persisted for a year or longer. The rise of neu- 
tralizing antibody as measured by the neutralization test in cotton rats paral- 
leled  the  rise  of  fluorescent-staining antibody.  Neither  the  cold  agglutinin 
nor  the streptococcus  MG agglutinin was  found to be  related antigenically 
to the specific  PAP antibody. This was shown clearly by the absorption and 
animal immunization experiments and also by the fact that the  PAP  anti- 
body persisted long after the cold and MG agglutinins had returned to normal 
levels. The fact that a  certain percentage of PAP convalescent serum contain 
the cold and streptococcus MG agglutinins remains unexplained. 
At  this  point,  we  wish to  clarify an  observation previously reported  (1) 
that absorption of PAP sera with MG organisms lowered the PAP fluorescent- 
staining antibody titer. In light of the more recent discovery of the enhancing 
effect of a  serum factor which is likely to be components of complement (4), 
it is clear now that the agglutination of ~IG organisms removes this factor 
rather than the antibody itself from the serum and hence affects the antibody 
titer. When the titration of serum absorbed with MG organisms was carried 
out in the presence of fresh normal human serum, the antibody titer was not 
affected. 
The present study was planned to develop a  specific  serological diagnostic 
test for PAP infection. An earlier report from this laboratory (3)  has shown 
that the test is specific for PAP and has no cross-reactions with other commonly 
known agents causing pulmonary infections. Among three groups representing 
89 patients with non-hacterial pneumonia which we have studied,  57  to  90 
per cent were diagnosed as PAP by the fluorescent-antlbody staining technic. 
The group in which 90 per cent gave positive reactions consisted of patients 
from three outbreaks of pneumonia in a  boys' private school. Each  of  these 
patients was seen and diagnosed as PAP by one of the authors (J. T. H.). The 
other two groups of patients were not as carefully selected. This may account 
for the difference in favor of a higher percentage of positives in the first group. 
The etiology of the illness in the patients negative for PAP antibody was not 
determined.  It  is  likely that  the  PAP  virus  may cause  milder  respiratory 
infections without the development of pneumonia (9, 16). With a specific sero- 
logical test available now, it should be feasible to study the epidemiology of 
this illness by serological survey. C.  LIU, M.  D.  EATON, J.  T. HEYL  555 
SUMMARY 
By using the indirect method of fluorescent staining to study the antibody 
response  in  patients  with  primary atypical  pneumonai  associated  with  the 
development of cold agglutinln, it was found that the PAP antibody developed 
during the 2nd and 3rd week of the illness, and persisted for over a year, and 
is not  related  to  the  cold and  streptococcus MG agglufinln.%  The develop- 
ment of the PAP  fluorescent  staining  antibody  paralleled  the neutralizing 
antibody for the PAP virus as tested in cotton rats.  The sensitivity of this 
specific serological test was  indicated by the observation that  67  to 92  per 
cent of the patients in several outbreaks of PAP showed a  rise of antibody 
titer during convalescence. Absorption of the sera with various tissue powders 
did not affect the PAP antibody detected by this method. 
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